These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8999846)

  • 1. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells.
    Lavie Y; Cao Ht; Volner A; Lucci A; Han TY; Geffen V; Giuliano AE; Cabot MC
    J Biol Chem; 1997 Jan; 272(3):1682-7. PubMed ID: 8999846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance.
    Liu YY; Han TY; Giuliano AE; Hansen N; Cabot MC
    J Biol Chem; 2000 Mar; 275(10):7138-43. PubMed ID: 10702281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells.
    Lucci A; Han TY; Liu YY; Giuliano AE; Cabot MC
    Cancer; 1999 Jul; 86(2):300-11. PubMed ID: 10421266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells.
    Liu YY; Han TY; Giuliano AE; Cabot MC
    J Biol Chem; 1999 Jan; 274(2):1140-6. PubMed ID: 9873062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceramide glycosylation potentiates cellular multidrug resistance.
    Liu YY; Han TY; Giuliano AE; Cabot MC
    FASEB J; 2001 Mar; 15(3):719-30. PubMed ID: 11259390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics.
    Lucci A; Han TY; Liu YY; Giuliano AE; Cabot MC
    Int J Oncol; 1999 Sep; 15(3):541-6. PubMed ID: 10427137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceramide toxicity and metabolism differ in wild-type and multidrug-resistant cancer cells.
    Lucci A; Giuliano AE; Han TY; Dinur T; Liu YY; Senchenkov A; Cabot MC
    Int J Oncol; 1999 Sep; 15(3):535-40. PubMed ID: 10427136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells.
    Tyler A; Johansson A; Karlsson T; Gudey SK; Brännström T; Grankvist K; Behnam-Motlagh P
    Exp Cell Res; 2015 Aug; 336(1):23-32. PubMed ID: 26004871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of glucosylceramides in multidrug-resistant cancer cells.
    Lavie Y; Cao H; Bursten SL; Giuliano AE; Cabot MC
    J Biol Chem; 1996 Aug; 271(32):19530-6. PubMed ID: 8702646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines.
    Kim JH; Chung JB; Park IS; Kim BS; Yoo NC; Choi JH; Roh JK; Kim HS; Kwon OH; Lee KS
    Yonsei Med J; 1993 Mar; 34(1):35-44. PubMed ID: 8397460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of P-glycoprotein in HeLa cells confers resistance to ceramide cytotoxicity.
    Chapman JV; Gouazé-Andersson V; Cabot MC
    Int J Oncol; 2010 Dec; 37(6):1591-7. PubMed ID: 21042729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy.
    Gouazé V; Yu JY; Bleicher RJ; Han TY; Liu YY; Wang H; Gottesman MM; Bitterman A; Giuliano AE; Cabot MC
    Mol Cancer Ther; 2004 May; 3(5):633-9. PubMed ID: 15141021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen retards glycosphingolipid metabolism in human cancer cells.
    Cabot MC; Giuliano AE; Volner A; Han TY
    FEBS Lett; 1996 Sep; 394(2):129-31. PubMed ID: 8843149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.
    Gouazé V; Liu YY; Prickett CS; Yu JY; Giuliano AE; Cabot MC
    Cancer Res; 2005 May; 65(9):3861-7. PubMed ID: 15867385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs.
    Shabbits JA; Mayer LD
    Mol Cancer Ther; 2002 Jan; 1(3):205-13. PubMed ID: 12467215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells.
    Liu YY; Han TY; Yu JY; Bitterman A; Le A; Giuliano AE; Cabot MC
    J Lipid Res; 2004 May; 45(5):933-40. PubMed ID: 14967819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
    De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S
    Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
    Norris-Cervetto E; Callaghan R; Platt FM; Dwek RA; Butters TD
    J Biol Chem; 2004 Sep; 279(39):40412-8. PubMed ID: 15263008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
    Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
    Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glycosphingolipid biosynthesis reverts multidrug resistance by differentially modulating ABC transporters in chronic myeloid leukemias.
    Salustiano EJ; da Costa KM; Freire-de-Lima L; Mendonça-Previato L; Previato JO
    J Biol Chem; 2020 May; 295(19):6457-6471. PubMed ID: 32229586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.